PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 11 2025
0mins
Source: Globenewswire
Company Participation in Conferences: PMV Pharmaceuticals, Inc. will have its CEO and Chief Development Officer participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025, and the TD Cowen 45th Annual Health Care Conference on March 4, 2025, along with one-on-one investor meetings.
About PMV Pharma: The company specializes in precision oncology, focusing on small molecule therapies targeting p53 mutations, which are present in about half of all cancers, and was co-founded by Dr. Arnold Levine, a pioneer in p53 biology.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
